Decoy Therapeutics (DCOY) Other Non-Current Liabilities (2014 - 2019)
Decoy Therapeutics (DCOY) posted quarterly Other Non-Current Liabilities of $317762.0 for Q4 2019, up 1957.78% quarter-over-quarter from $15442.0 in Q1 2016.
Decoy Therapeutics (DCOY) Other Non-Current Liabilities (2014 - 2019) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Other Non-Current Liabilities for 4 consecutive years, with $317762.0 the latest figure, recorded in Q4 2019.
- In Q4 2019, Other Non-Current Liabilities changed N/A year-over-year to $317762.0; the TTM figure through Dec 2019 stood at $317762.0 (changed N/A YoY), while the FY2019 annual figure was $317762.0, changed N/A from the prior year.
- Other Non-Current Liabilities rose to $317762.0 in Q4 2019 per DCOY's latest filing, from $15442.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $415442.0 in Q1 2015 and bottomed at $15442.0 in Q4 2015.
- Historically, Other Non-Current Liabilities has averaged $265828.7 across 3 years, with a median of $366602.0 in 2015.
- Annual changes were most pronounced in 2015 — Other Non-Current Liabilities changed 0.0% — and 2016, when it slumped 96.28%.
- Decoy Therapeutics' Other Non-Current Liabilities stood at $15442.0 in 2015, then changed by 0.0% to $15442.0 in 2016, then jumped by 1957.78% to $317762.0 in 2019.
- Business Quant data shows DCOY's Other Non-Current Liabilities at $317762.0 in Q4 2019, $15442.0 in Q1 2016, and $15442.0 in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.60 Bn | 130.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.93 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.06 Bn | 59.88 Bn | 1.37 Bn |
| 4 | Moderna | 56.22 Bn | 51.08 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.65 Bn | 28.34 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - |
| 10 | Decoy Therapeutics | 1.82 Mn | 1.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 317,762.00 |
| Mar 31, 2016 | 15,442.00 |
| Dec 31, 2015 | 15,442.00 |
| Sep 30, 2015 | 415,442.00 |
| Jun 30, 2015 | 415,442.00 |
| Mar 31, 2015 | 415,442.00 |
| Dec 31, 2014 | 15,442.00 |